Traditional Classification and Novel Subtyping Systems for Bladder Cancer

Area of Science:

• Urology
• Oncology
• Genetics

Background:

• Bladder cancer is a common urinary system tumor, causing significant mortality.
• Current European Organization for Research and Treatment of Cancer (EOTRC) classification for non-muscular invasive bladder cancer (NMIBC) relies on pathological parameters to assess recurrence and progression risks.
• Traditional systems, while clinically convenient, do not fully capture intrinsic tumor characteristics, leading to varied biological behaviors and imprecise individual risk prediction.

Purpose of the Study:

• To explore the potential of genetics-based molecular subtyping for bladder cancer.
• To compare molecular subtyping with traditional pathological classification systems.
• To highlight the advantages of molecular subtyping in providing comprehensive tumor biological information.

Main Methods:

• Review of traditional bladder cancer classification systems based on pathology.
• Discussion of advancements in sequencing and other technologies for molecular subtyping.
• Comparative analysis of information provided by traditional versus molecular classification.

Main Results:

• Traditional pathological parameters have limitations in reflecting intrinsic bladder cancer characteristics.
• Molecular subtyping provides richer biological data compared to traditional methods.
• Molecular subtyping is emerging as a promising approach for bladder cancer classification.

Conclusions:

• Genetics-based molecular subtyping offers a more detailed understanding of bladder cancer.
• Molecular subtyping is expected to enhance or potentially replace traditional classification systems in the future.
• This approach holds promise for improved prediction of recurrence and progression in bladder cancer patients.